Initial reports on antiproteinuric effect of pefloxacine in small grou
ps of patients with minimal-change nephropathy (MCN) and focal and seg
mental glomerulosclerosis (FSGS) have not been confirmed in other pape
rs. To assess its antiproteinuric effect in experimental animals we ad
ministered pefloxacine to rats with adriamycin nephropathy showing mor
phological changes resembling human minimal-change disease or focal se
gmental glomerulosclerosis, and clinically with full-blown nephrotic s
yndrome. Pefloxacine treatment was at least partially effective in pre
venting further increase of proteinuria in rats with adriamycin nephro
pathy. The mechanism of this effect remains unclear and deserves furth
er studies concentrating on the glomerular cytokine network and glomer
ular production of reactive oxygen species.